What stage does New Enterprise Associates (NEA) invest at?

New Enterprise Associates (NEA) invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is New Enterprise Associates (NEA)'s typical check size?

New Enterprise Associates (NEA) typically writes checks of $200K – $40M.

Where is New Enterprise Associates (NEA) located?

New Enterprise Associates (NEA) is headquartered in Menlo Park, US.

Does New Enterprise Associates (NEA) lead rounds?

Yes, New Enterprise Associates (NEA) leads investment rounds.

New Enterprise Associates (NEA)

Venture capitalActively deploying

Menlo Park · Seed–Late Stage · 71 people tracked

Also known as NEA · Nea Management Company, Llc · New Enterprise Associates

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

NEA views venture investment as an enduring commitment to the people executing on innovative ideas rather than a transactional financial engagement. The firm partners with founders to support the realization of transformative concepts.

Invests inAI & Machine Learning Biotech Consumer Digital Health Enterprise Software Healthtech Sector AgnosticChinaEuropeIndiaMenlo ParkNorwayUnited KingdomUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Check

$200K – $40M

Menlo Park, CA, US

Leads rounds

Leads

Instruments

Equity

Founded

1978

AUM

$35.6B

Tracked investments

173

Team · 71 people

from the firm's website & curated & public directories

Aaron Jacobson· Partner· San Francisco, Californiain 𝕏

Aaron Jacobson joined NEA in 2011 and works with founders in AI, cybersecurity, developer tools, and robotics. Before NEA, he spent two years in M&A advisory at Qatalyst Partners in San Francisco. He graduated summa cum laude from the Jerome Fisher Program in Management & Technology at the University of Pennsylvania with dual B.S. degrees in economics and electrical engineering and a minor in math.

a•••@nea.comreveal

Ali Behbahani· General Partner· Menlo Park, CAin

Ali Behbahani, M.D., is a healthcare investor at NEA focused on the biopharmaceutical and medical device sectors. He joined NEA in 2007 and became a partner in 2013 before being promoted to General Partner in 2018. Earlier in his career he worked as a Venture Associate at Morgan Stanley Venture Partners, in business development at The Medicines Company, and as a healthcare investment banking analyst at Lehman Brothers. He holds an MD from the University of Pennsylvania School of Medicine and an MBA from the Wharton School.

a•••@nea.comreveal

Andrew Schoen· Partner, Technology Investing Team· Denver, Coloradoin 𝕏

Andrew Schoen is a Partner on NEA's Technology Investing Team, where he has worked since 2014. Before joining NEA, he was part of Blackstone's M&A team and co-founded Flicstart, which was acquired. He holds a master's degree as a Schwarzman Scholar and a bachelor's degree in economics and engineering from Cornell University.

Ann Bordetsky· Partner· San Francisco Bay Areain 𝕏

Arjun Jain· Partnerin

Arjun Jain is a Partner on the technology team at NEA, which he joined in 2021, focusing on consumer and enterprise investments as well as portfolio management. Before NEA, he was a merchant banker at The Raine Group in New York, working on M&A and growth equity deals across technology, media, and entertainment, and earlier worked in Sales & Trading at J.P. Morgan. He holds a BA in economics from Princeton University.

Blake Wu· Partner· Menlo Park, Californiain

Blake Wu joined NEA in 2014 and invests in digital health, including healthcare services and healthcare IT, as well as biopharmaceuticals. He previously worked in the private equity group at Ares Management focused on healthcare, and earlier held roles in investment banking at Moelis & Company and equity research at Barclays Capital. He holds a BS in economics from The Wharton School at the University of Pennsylvania.

b•••@nea.comreveal

Carmen Chang· Partner and Managing Director, Asia (Ex-India)· Menlo Park, Californiain

Carmen Chang is Partner and Managing Director, Asia (Ex-India) at NEA, where she focuses on the firm's deal flow and presence in China and other Asian markets after joining as a Special Senior Advisor in 2012. Before NEA, she was a Partner at Wilson Sonsini Goodrich & Rosati, leading its China practice and working on technology transactions and IPOs in China. She is affiliated with Stanford University's Center for International Security and Cooperation and is a fellow of the Rock Center for Corporate Governance.

c•••@nea.comreveal

Colin Bryant· Partner· San Francisco, Californiain

Danielle Lay· Partner, Technology Investing Team· Bay Areain 𝕏

Danielle Lay is a Partner on NEA's Technology Investing Team, investing from seed to growth in generational companies focused on AI applications and physical AI. Before joining NEA in 2017, she worked as an investment banker at Goldman Sachs. She holds a BA in Economics, Business Institutions and Chinese from Northwestern University.

Ed Mathers· Partner· Marylandin

Ed Mathers is a Partner on NEA's healthcare team, where he has worked since 2008, focusing on biotechnology and specialty pharmaceuticals investments. Before NEA, he was EVP of Corporate Development and Venture at MedImmune, contributing to its 2007 sale to AstraZeneca, and previously held roles at Inhale Therapeutic Systems and Glaxo Wellcome (now GSK). His investment interests include gene therapy, nonviral gene therapy, RNA editing, and immunology and inflammation.

e•••@nea.comreveal

Forest Baskett· General Partner· San Francisco, Californiain

Forest Baskett, PhD· General Partner, NEAin

Forest Baskett, a systems‑level technologist, co‑designed the Sun workstation with Andy Bechtolsheim, built a RISC at DEC that beat the VAX, served as SGI CTO, and retains founder ties.

Jonathan Golden· Partner· San Francisco, Californiain 𝕏

Lila Tretikov· Partner, Head of AI Strategyin 𝕏

Lila Tretikov is a Partner and Head of AI Strategy at NEA, investing across multiple stages, sectors, and geographies. Previously, she served as Deputy CTO at Microsoft leading AI transformation initiatives, and held executive roles including SVP at Engie and CEO of Terrawatt, where she oversaw the company's pivot toward new energy sources. She also served as CEO of Wikimedia Foundation, where she established the Wikipedia Endowment and developed the organization's AI strategy.

Lily Huang· Partner· San Francisco Bay Areain 𝕏

Liza Landsman· General Partner· New York, New Yorkin 𝕏

Liza Landsman alternates between venture investing and C‑suite roles (Stash, The Points Guy, President of Jet.com), bringing broad finance, retail and consumer internet operating depth to fintech and consumer firms.

Luke Pappas· Partner, Technology team· San Francisco Bay Areain 𝕏

Luke Pappas is a Partner on NEA's Technology team focused on consumer and enterprise investing. Previously, he worked in Technology Investment Banking at Morgan Stanley. He holds dual BS degrees in computer science and management science & engineering from Stanford University.

Madison Hawkinson· Partner· New York, New Yorkin 𝕏

Matthew McAviney· Partner· San Francisco, Californiain 𝕏

Michele Park· Investor, Healthcare Team

Michele Park is an investor at New Enterprise Associates focused on the biopharma sector. She previously held investor roles at Clarus Ventures (now Blackstone Life Sciences) and worked as a biotechnology research analyst at Credit Suisse and Piper Jaffray. She holds a PhD in molecular biology from Weill Cornell Graduate School of Medical Sciences, where she completed her dissertation at Memorial Sloan Kettering Cancer Center, and a BA in molecular biology from Princeton.

Mohamad Makhzoumi· General Partner· Menlo Park, Californiain

Mohamad Makhzoumi rose from healthcare investor to Co-CEO over two decades, now leading a diversified mega-fund and championing AI software that tackles administrative waste and back-office healthcare infrastructure.

m•••@nea.comreveal

Mustafa Neemuchwala· Partner· Dallas suburbs, Texasin

Mustafa is a Partner on NEA's Technology Investing Team, focusing on investments from seed to late-stage growth in AI, cybersecurity, infrastructure, defense, and frontier technologies. Before joining NEA in 2021, he advised on approximately $58 billion in technology M&A transactions at Qatalyst Partners, with expertise spanning frontier tech, infrastructure, application software, cybersecurity, fintech, and consumer internet. He holds degrees from the University of Texas at Austin in finance, liberal arts, computer science, and mathematics.

Patrick Kerins· General Partner· Marylandin

Paul Walker· Partner and Co-Head of Healthcare, NEA

Paul Walker leverages 25+ years in public biotech markets, biochemistry training and a CFA, focusing on later-stage/public/crossover biotech as a contrarian, patient multi-year partner to public companies recovering from setbacks.

p•••@nea.comreveal

Peter Sonsini· General Partner, NEAin 𝕏

Peter Sonsini rose from principal to Head of Enterprise Software, backed cloud infrastructure and developer platforms early, and now specializes in infrastructure-security and AI-infrastructure startups, led Perplexity AI's Series A.

Philip Chopin· Managing Director, Head of Europe· Londonin 𝕏

Philip Chopin is Managing Director and Head of Europe at New Enterprise Associates, leading the firm's European investment operations from London. Previously, he was a Partner at 83North where he invested in and supported numerous portfolio companies. His career began at BCG, where he worked as a Project Leader, and he holds an MBA from Kellogg and a Master's degree from Grenoble Ecole de Management.

Rick Yang· Partner· San Francisco, Californiain 𝕏

Rick Yang grew up in one firm over nearly two decades, focusing on consumer behavior and financial infrastructure and championing consumer-grade experiences in opaque markets like healthcare.

r•••@nea.comreveal

Scott Gottlieb· Partner· Washington, District of Columbiain 𝕏

Scott Gottlieb is a Partner on NEA's Healthcare team. He was a Venture Partner at NEA from 2007 to 2017 before serving as the 23rd Commissioner of the U.S. Food and Drug Administration from 2017 to 2019. A physician and policy expert, he focuses on healthcare innovation, including life sciences platforms and the application of AI to drug development and healthcare delivery.

p•••@nea.comreveal

Scott Sandell· Managing Partner· Palm Beach, FLin 𝕏

Scott Sandell joined NEA in 1996, became managing general partner in 2016, and now serves as the firm's executive chairman and chief investment officer. His investments span Salesforce, Workday, Tableau and Robinhood, with Cloudflare — where he is lead independent director — standing out as his defining deal. A Dartmouth and Stanford GSB graduate, he is also a public advocate for employing people with disabilities, drawing on his own experience with dyslexia.

s•••@nea.comreveal

Tak Cheung· Partner· Menlo Park, Californiain

Tiffany Luck· Partner· San Francisco Bay Areain 𝕏

Tiffany Luck is a Partner at New Enterprise Associates focused on early-stage AI, APIs, and B2B SaaS investments. Previously, she was a Partner at GGV Capital where she led investments in companies including Pinwheel, Mindee, Stream, Electric.ai, Fairmarkit, Workboard, and Vic.ai. Her background includes roles in marketing and business development at Forbes, Lot18, and Amazon, as well as technology investment banking at Morgan Stanley advising clients such as Github, Netflix, and Zoom.

Tony Florence· General Partner· New York, New Yorkin 𝕏

Tony Florence is a hands-on, long-term board partner and trusted mentor who uses his former head-of-tech experience and Co-CEO leadership to support brand-driven, digital-commerce breakouts like Casper and Goop.

t•••@nea.comreveal

Vanessa Larco· Partner· San Francisco Bay Areain 𝕏

Alex Sharata· Investor· Miami, Floridain 𝕏

Alex Sharata is an investor at New Enterprise Associates who joined the firm in 2020 to lead its growth-stage investing practice across enterprise, fintech, and consumer sectors. Previously, he was an investor at Vista Equity Partners focused on majority investments in enterprise software and co-founded Fractal, a mobile app security company that was acquired in 2017. He holds a B.S. in computer science and economics from Johns Hopkins University.

Ayush Goradia· Principal

Hui Cheng· Principal, Healthcare Investing Teamin

Hui Cheng is a Principal at New Enterprise Associates focusing on digital health investing across all stages. She previously served as Vice President at Town Hall Ventures, where she led early to mid-stage healthcare services investments. She began her career at Bain & Company in the healthcare and private equity practice and held business operations roles at an early-stage software startup. She holds a BA in Government from Dartmouth College.

Hunter Worland· Principal

J.C. Lopez· Principal· San Francisco Bay Areain

James Buxton· Principalin

James Buxton is a Principal on NEA's Healthcare team focused on life sciences investing. He trained as a cardiothoracic surgeon before transitioning to venture capital, having previously worked at SR One Capital Management, Morgan Stanley, and New Rhein Healthcare Investors. He holds a BSc and MD from University College London and an MBA from The Wharton School.

James Kaplan· Principal

Jess Ou· Principal· San Francisco Bay Areain 𝕏

Lulu Xu· Principal

Mason Murray· Principal

Tiffany Le· Principal· San Francisco, Californiain 𝕏

Brooke Seawell· Venture Partner· Bethesda, Marylandin

Brooke joined NEA in 2005 as a Venture Partner with expertise in software, systems, and internet investments. He brings over 40 years of experience in technology finance and operations, with a 25-year background as an operating executive at technology companies, having taken three public and sold one to Sun Microsystems. At NEA, he leverages his founding and operating experience to mentor portfolio company operators and serves on the boards of NVIDIA, Tenable, and GoodLeap.

Greg Papadopoulos· Venture Partner· San Francisco Bay Areain

Greg joined NEA as Venture Partner in 2010 and focuses on early-stage systems, software, and deep/hard-tech companies. Previously he served as EVP and CTO at Sun Microsystems and was an Associate Professor of EECS at MIT. Earlier in his career, he held engineering positions at HP and Honeywell, and co-founded companies in video conferencing, AI accelerators, portable PCs, and computational fluid dynamics.

Hilarie Koplow-McAdams· Venture Partner· Menlo Park, Californiain 𝕏

Hilarie is a Venture Partner at NEA focused on enterprise software and services. She spent three decades in operating and board roles at growth-stage software companies, including serving as President at New Relic and President of Worldwide Sales at Salesforce. She began her career at Oracle and Intuit, and holds a master's degree in public policy from the University of Chicago and a bachelor's degree from Mills College.

Jeff Immelt· Venture Partner· Menlo Park, Californiain 𝕏

Jeff Immelt is a Venture Partner at NEA who previously served as Chairman and CEO of GE for 16 years, where he led strategic and organizational transformation. He brings experience in business leadership across diverse industries and focuses on healthcare, industrial automation, clean tech, and IoT investments. Immelt holds a BA in applied mathematics from Dartmouth College and an MBA from Harvard University.

Kavita Patel· Venture Advisor, Healthcare Team· Washington, District of Columbiain 𝕏

Kavita Patel is a Venture Advisor on NEA's Healthcare team, joining the firm in 2017. She holds an MD from the University of Texas Health Science Center and an MS in health services research from UCLA, and has experience as both a practicing physician and researcher. Previously she served in the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement, and currently serves as a Nonresident Fellow at The Brookings Institution.

Mark Hawkins· Venture Partner· United Statesin 𝕏

Mark Hawkins is a Venture Partner at NEA focused on technology investments, joining the firm in 2023. He previously served as President and CFO of Salesforce and held executive financial roles at Autodesk, Logitech, Dell, and HP. He holds a BA in operations management from Michigan State University, an MBA from the University of Colorado, and completed the Advanced Management Program at Harvard Business School.

Mike O'Dell· Venture Partner· United States

Ron Bernal· Venture Partner· Denver, Coloradoin

Sheila Lirio Marcelo· Venture Partner· New York, New Yorkin 𝕏

Albert Lee· Advisor· New York, New Yorkin 𝕏

Alexa Grabelle· Associate

Antony Yang· Dublin, Ohioin

Aya Somai· Associate

Brandon Christie· New York, New Yorkin 𝕏

Carol Gallagher· Advisor· Californiain 𝕏

Claudia Fan Munce· Venture Advisor

Danielle Ezratty· Investor

Danielle Ezratty joined NEA in 2023 to focus on digital health investments. She previously worked at Clayton, Dubilier & Rice on its healthcare team conducting growth and buyout investing in healthcare services. Before that, she spent time at Morgan Stanley's Investment Banking division advising on M&A transactions in natural resources and global industrials. She holds a BS in economics with a finance concentration from Duke University, where she graduated Phi Beta Kappa, summa cum laude.

Justine Potemkin· Investor· New York Cityin

Kemi Odusan· Investor· United Kingdomin 𝕏

Kevin Deng· Associate, Healthcare Investing Team· Not specifiedin

Kevin joined NEA in 2024 as an Associate on the Healthcare Investing Team, investing across all stages. He previously worked in the Healthcare Investment Banking group at Goldman Sachs, focusing on M&A and capital markets advisory for biopharma and healthcare services companies. He holds a BA in Computational Biology and a BS in Economics from the University of Pennsylvania, where he graduated summa cum laude.

Madison Faulkner· Venture Advisor

Michael Li· Investor· New York, New Yorkin

Neehaar Gandhi· Investor, Technology team· Not specified on pagein

Neehaar Gandhi is an investor at NEA focused on growth-stage investments in the technology sector. He previously worked at Fifth Wall and The Raine Group, supporting companies across physical world and media/tech/telecom ecosystems respectively. He graduated from Yale University with dual degrees in Statistics & Data Science and Environmental Studies.

Perry Wallack· Associate

Ryan Psik· Associate

Thomas Joshi· Associate

Zak Burns· Associate· New York, New Yorkin 𝕏

What they invest in

from 108 of 173 portfolio companies

AI & Machine Learning ×33Enterprise Software ×31Healthtech ×27Biotech ×26Developer Tools ×20SaaS ×18Cloud Computing ×14Data & Infrastructure ×12

HQs:United States×143United Kingdom×1Sweden×1

Investments · 173 tracked

founders shown can be your intro path

Monte Rosa Therapeuticsmonterosatx.comin 𝕏NASDAQ: GLUE✓ verified

Monte Rosa Therapeutics is a biopharmaceutical company developing molecular glue degrader (MGD) therapeutics using its QuEEN discovery engine, targeting oncology, neuroscience, and immune-mediated diseases.

AI & Machine LearningBiotechHealthtechBoston, US

Alexander Mayweg(Director)Bradley Bolzon(Director)Markus Warmuth(M.D., Chief Executive Officer)Ali Behbahani(Director)Kim Blackwell(Director)Sharon Townson(Ph.D., Chief Scientific Officer)

Board seatAli Behbahani· per SEC Form D

BuzzFeedbuzzfeed.com𝕏NASDAQ: BZFDSEC filingmedium confidence

BuzzFeed is a digital media company that produces entertainment, news, and content across pop culture, food, and commerce for online audiences.

ConsumerCreator EconomyMedia & EntertainmentNew York, US

Jonah Peretti(Director and President of AI)Patrick Kerins(Director)Mark Frackt(Executive Officer)Scott English(Director)Will Porteous(Director)Greg Coleman(Executive Officer, Director)

Board seatPatrick Kerins· per SEC Form D · $251.5K raise · filed Feb 2015

Coursera (Exit)coursera.orgin 𝕏NYSE: COUR

Coursera for Teams provides enterprise learning management and employee upskilling through online courses and professional certificates from universities and industry partners.

EdTechEnterprise SoftwareSaaSMountain View, US

Dan Avida(Director)John Doerr(Director)Daphne Koller(Executive Officer, Director)Richard Levin(Executive Officer, Director)Andrew Ng(Director)

Board seatScott Sandell· per SEC Form D

CVRxcvrx.comin 𝕏NASDAQ: CVRXSEC filingmedium confidence

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)Geoff Pardo(Director)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)

Board seatAli Behbahani· per SEC Form D · $93M raise · filed May 2019

Mirum PharmaceuticalsNASDAQ: MIRMSEC filingmedium confidence

Rare liver disease treatment company.

San Diego, US

Board seatEdward T. MathersEd Mathers· per SEC Form D · $10M raise · filed Dec 2020

NextNav HoldingsNASDAQ: NNSEC filingmedium confidence

Mclean, US

Ganesh Pattabiraman(Executive Officer, Director)Eric Swank(Chief Financial Officer)Bandel Carano(Director)Matt Skaruppa(Director)James Fleming(Director)Gary Parsons(Executive Officer, Director)

Board seatPeter Barris· per SEC Form D · $35M raise · filed Sep 2016

Nkarta, Inc.NASDAQ: NKTXSEC filingmedium confidence

Developing allogeneic or off-the-shelf cell therapies for cancer and auto-immune disease based on Natural Killer cells.

South San Francisco, US

Board seatAli Behbahani· per SEC Form D · $114.6M raise · filed Sep 2019

Onkure Therapeutics Inconkuretherapeutics.comin 𝕏NASDAQ: OKURSEC filingmedium confidence

OnKure discovers and develops precision medicines targeting specific cancer drivers and vascular anomalies using structure-based drug design.

BiotechDigital HealthMedical DevicesBoulder, US

Jason Leverone(Executive Officer)Samuel Agresta(Executive Officer)Dylan Hartley(Executive Officer)Nicholas Saccomano(Executive Officer, Director)Scott Weiner(Director)Wendy Johnson(Executive Officer)

Board seatEdward T. Mathers· per SEC Form D · $65M raise · filed Oct 2024

Rhythm PharmaceuticalsNASDAQ: RYTMSEC filingmedium confidence

BiotechBoston, US

Edward T. Mathers(Director)David J. McGirr(Director)Jonathan Silverstein(Director)Keith Gottesdiener(Executive Officer, Director)David P. Meeker, M.D.(Director)Neil Exter(Director)

Board seatEdward T. Mathers· per SEC Form D · $40M raise · filed Dec 2015

Robinhood MarketsNASDAQ: HOODSEC filingmedium confidence

Menlo Park, US

BAIJU BHATT(Executive Officer, Director)VLADIMIR TENEV(Executive Officer, Director)JASON WARNICK(Executive Officer)GRETCHEN HOWARD(Executive Officer)SCOTT SANDELL(Director)JAN HAMMER(Director)

Board seatScott Sandell· per SEC Form D · $688.3M raise · filed Oct 2020

Senti Biosciencessentibio.comin 𝕏NASDAQ: SNTISEC filingmedium confidence

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

Tim Lu(Co-Founder and Chief Executive Officer)James Collins(Director)Kanya Rajangam(President, Head of Research & Development and Chief Medical Officer)Yvonne Li(Executive Officer)Philip Lee(Executive Officer)Alex Kolicich(Director)

Board seatEd Mathers· per SEC Form D · $53.4M raise · filed Feb 2018

Sprout SocialNASDAQ: SPT

Chicago, US

Aaron Rankin(Executive Officer, Director)Peter Barris(Director)Eric Lefkofksy(Director)Justyn Howard(Executive Officer, Director)Jason Kreuziger(Director)

Board seatPeter Barris· per SEC Form D

SpyGlassPharma, Inc.NASDAQ: SGPSEC filingmedium confidence

HealthtechAliso Viejo, US

Jake Merrill(Director)Malik Kahook(Executive Officer, Director)Geoff Pardo(Director)Bilal Khan(Director)Cynthia Yee(Director)Roger Zhang(Director)

Board seatAli Behbahani· per SEC Form D · $75M raise · filed Jun 2025

Synlogicsynlogictx.comin 𝕏OTC: SYBXSEC filingmedium confidence

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

Ed Mathers(Director)Chau Khuong(Director)Bharatt Chowrira(Executive Officer)Ankit Mahadevia(Director)Michael Sheahan(Executive Officer)Peter Barrett(Director)

Board seatEd Mathers· per SEC Form D · $40.6M raise · filed Feb 2016

Tempus LabsNASDAQ: TEMSEC filinghigh confidence

Chicago, US

Brad Keywell(Director)Peter Barris(Director)Erik Phelps(Executive Officer)Eric Lefkofsky(Executive Officer, Director)Ryan Fukushima(Executive Officer)

Board seatScott GottliebPeter Barris· per SEC Form D · $10M raise · filed Oct 2022

Twiliotwilio.comin 𝕏NYSE: TWLOSEC filingmedium confidence

Twilio provides a cloud-based communications platform that enables businesses to integrate voice, messaging, and video into applications using APIs.

Cloud ComputingDeveloper ToolsEnterprise SoftwareSan Francisco, US

Jeff Lawson(Founder)inEvan Cooke(Director)Scott Raney(Director)Lee Kirkpatrick(Executive Officer)Roy Ng(Executive Officer)Karyn Smith(Executive Officer)

Board seatJeff Immelt· per SEC Form D · $378.2M raise · filed Jul 2021

MongoDBmongodb.com𝕏NASDAQ: MDB

MongoDB is a cloud database company that provides Atlas, a multi-cloud data platform for transactional, search, and generative AI workloads, along with enterprise on-premises options and integration tools for developers and partners.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsNew York, US

Chirantan 'CJ' Desai(President & CEO)Dwight Merriman(Director)Roelof Botha(Director)Sydney Carey(Chief Financial Officer)Dev Ittycheria(Chief Executive Officer)Charles M. Hazard, Jr.(Director)

IonQionq.comin 𝕏✓ verified

IonQ develops trapped ion quantum computers along with quantum networking, sensing, and security technology, aimed at solving problems beyond the reach of classical systems.

Deep TechHardwareQuantum ComputingCollege Park, US

Jungsang Kim(Co-founder)Andrew Schoen(Director)David Moehring(Executive Officer, Director)Blake Byers(Director)Christopher Monroe(Executive Officer)Ron Bernal(Director)

Board seatRon BernalAndrew Schoen· per SEC Form D

Abcuroabcuro.com✓ verified

Abcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.

BiotechHealthtechNewton, US

John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Ryan Berry(Director)Donald McCarthy(Director)John Edwards(Director)Yajun Xu(Director)

Active Remote Desktopsplashtop.comin 𝕏✓ verified

Splashtop is a remote access and support platform that enables users to securely access and control computers from any device with high performance, up to 4K quality at 60fps.

Cloud ComputingCybersecurityDeveloper ToolsEnterprise SoftwareSaaS

Mark LeeRobert HaThomas DengPhilip Sheu

Cohere Technologiescohere-technologies.comin 𝕏✓ verified

Cohere Technologies develops Universal Spectrum Multiplier (USM) software that improves 4G, 5G, and Multi-G mobile networks across FDD and TDD spectrum bands, along with Pulsone Technology based on the Zak-OTFS waveform for ISAC and NTN.

AI & Machine LearningCloud ComputingDeep TechEnterprise SoftwareSanta Clara, US

Shlomo Rakib(Executive Officer, Director)Ron Bernal(Director)Krishna Kolluri(Director)Chris Schaepe(Director)

Shape Therapeuticsshapetx.comin 𝕏✓ verified

ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.

AI & Machine LearningBiotechDeep Tech

Josef von Rickenbach, PhD(Co-Founder)in

Smartcarsmartcar.comin 𝕏✓ verified

Smartcar provides an API and integration platform that enables access to connected vehicle data, powering mobility applications and services for consumers and businesses including insurance savings, car-sharing, and electric vehicle adoption.

IoTMobility & TransportationSaaS

Sanketh Katta(Co-Founder)

Valarianvalarian.com✓ verified

Valarian builds ACRA, an infrastructure platform for organizations requiring high levels of control, privacy, and compliance in their digital environments.

Cloud ComputingCybersecurityEnterprise SoftwareLondon, GB

Max Buchan(Co-founder & CEO)Josh McLaughlin(Co-founder & COO)

→ Arkestroarkestro.cominSEC filingmedium confidence

Arkestro provides intelligent procurement software that automates supplier quote collection and comparison for enterprise procurement teams.

AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US

Edmund LeikenBen Leiken(CTO)Rob Desantis(Co-founder)Cindy Padnos(Director)Edmund Adam Zagorin(Executive Officer, Director)Martin Meyer(Executive Officer)

Board seatJeff Immelt· per SEC Form D · $40.3M raise · filed Feb 2023

858 Therapeutics, Inc.SEC filingmedium confidence

San Diego, US

Board seatAli Behbahani· per SEC Form D · $50.4M raise · filed Jul 2024

Aigenaigen.ioin 𝕏SEC filingmedium confidence

Seattle, US

Dan Fitzgerald(Director)Richard Wurden(Executive Officer, Director)Andrew Schoen(Director)Kenny Lee(Executive Officer, Director)Henry Magun(Director)

Board seatAndrew Schoen· per SEC Form D · $10M raise · filed Aug 2025

Akouosakouos.comSEC filingmedium confidence

BiotechBrookline, US

Emmanuel Simons(Executive Officer, Director)Ed Mathers(Director)Kush Parmar(Director)

Board seatEd Mathers· per SEC Form D · $7.6M raise · filed Nov 2017

AppSheetappsheet.cominSEC filingmedium confidence

AppSheet is a no-code application development platform that enables users to build apps and automated workflows without coding, using AI-powered tools and integrations with Google Workspace and third-party services.

Developer ToolsEnterprise SoftwareBellevue, US

Praveen Seshadri(President and Chief Executive Officer of the Issuer)Greg Papadopoulos(Director of the Issuer)Ravi Mohan(Director of the Issuer)

Board seatGreg Papadopoulos· per SEC Form D · $19.3M raise · filed Apr 2019

Aptive SystemsSEC filingmedium confidence

East Brunswick, US

Andrew McElroy(Executive Officer, Director)Michael C. Brown, Jr.(Director)Jonathan Salama(Executive Officer, Director)

Board seatColin BryantCarmen Chang· per SEC Form D · $34.1M raise · filed Jun 2023

Aquabyte, Inc.SEC filingmedium confidence

San Francisco, US

Board seatGreg Papadopoulos· per SEC Form D · $25M raise · filed Jan 2022

ArazSEC filingmedium confidence

San Mateo, US

Aaron Jacobson(Director)Hojjat Jafarpour Gharagozi Mola(Executive Officer, Director)

Board seatAaron Jacobson· per SEC Form D · $10.2M raise · filed Jan 2021

Arcellxarcellx.comSEC filinghigh confidence

Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.

BiotechHealthtechGaithersburg, US

Han Lee(Executive Officer)Lewis T. Rusty Williams(Director)Jill Carroll(Director)David Lubner(Director)Ali Behbahani(Director)Rami Elghandour(Executive Officer, Director)

Board seatKavita PatelAli Behbahani· per SEC Form D · $10M raise · filed Mar 2022

Aset TherapeuticsSEC filingmedium confidence

BiotechStony Brook, US

Elizabeth Buck(Executive Officer)Garry E Menzel(Director)David M Epstein(Executive Officer, Director)Brad Bolzon(Director)Alexander Mayweg(Director)

Board seatAli Behbahani· per SEC Form D · $87.2M raise · filed Jul 2019

Automation Anywhere, Inc.SEC filingmedium confidence

San Jose, US

Board seatScott Sandell· per SEC Form D · $450M raise · filed Dec 2019

Belong HealthSEC filingmedium confidence

HealthtechRadnor, US

Douglas Duane Byrd(Executive Officer)

Board seatMohamad Makhzoumi· per SEC Form D · $441.9K raise · filed Dec 2025

Beyond Identitybeyondidentity.comin 𝕏SEC filinghigh confidence

Beyond Identity provides an authentication and identity platform built with security as the foundational design principle, eliminating passwords and validating both users and devices.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSNew York, US

Louis MarascioinNelson MeloinJasson Casey, PhDinHilarie Koplow-McAdams(Director)Thomas Jermoluk(Executive Officer, Director)James Clark(Director)

Board seatHilarie Koplow-McAdamsForest Baskett· per SEC Form D · $30M raise · filed Apr 2020

BitglassSEC filingmedium confidence

Campbell, US

BALAS NATARAJAN KAUSIK(Executive Officer, Director)MATTHEW HOWARD(Director)CHRISTOPHER CHAN(Executive Officer)FOREST BASKETT(Director)ANURAG KAHOL(Executive Officer)ANDREW URUSHIMA(Executive Officer)

Board seatAaron JacobsonScott SandellForest Baskett· per SEC Form D · $69M raise · filed Apr 2019

Branch Metrics, Inc.SEC filingmedium confidence

Palo Alto, US

Mar Hershenson(Director)Maria Madalina Seghete(Executive Officer, Director)Michael Charles Molinet(Executive Officer, Director, Promoter)Alexander John Austin(Executive Officer, Director, Promoter)Scott Sandell(Director)

Board seatScott SandellForest Baskett· per SEC Form D · $300M raise · filed Feb 2022

Bright HealthSEC filinghigh confidence

HealthtechMinneapolis, US

Keith Nelsen(Executive Officer)Jeff Folick(Director)Kedrick Adkins(Director)G. Mike Mikan(Executive Officer, Director)Adair Newhall(Director)Mohamad Makhzoumi(Director)

Board seatMohamad MakhzoumiJeff Immelt· per SEC Form D · $500M raise · filed Sep 2020

Built Roboticsbuiltrobotics.comin 𝕏SEC filingmedium confidence

Built Robotics develops autonomous robotics systems for solar energy installation, specifically for piling, trenching, and safety applications in solar farm construction.

CleantechConstruction TechEnergyHardwareRoboticsUnited States, US

Noah Ready-Campbell(Founder & CEO)Forest Baskett(Director)

Board seatForest Baskett· per SEC Form D · $15.1M raise · filed Oct 2017

Burrowburrow.comin 𝕏SEC filingmedium confidence

Burrow designs and sells modular furniture with an emphasis on quality, affordability, and fast delivery.

ConsumerE-commerceNew York City, US

Stephen Kuhl(Founder/CEO)inKabeer Chopra(Founder)inTony Florence(Director)Steven Finnern(Executive Officer)

Board seatTony Florence· per SEC Form D · $14M raise · filed Mar 2018

Cardionomiccardionomicinc.comSEC filingmedium confidence

HealthtechForest Lake, US

Karen Shanahan(Director)Ali Behbahani(Director)Steve Goedeke(Executive Officer, Director)William Abraham(Director)Michael DeMane(Director)Jay Graf(Director)

Board seatAli Behbahani· per SEC Form D · $21.8M raise · filed Oct 2015

Catalyticcatalytic.comin 𝕏SEC filingmedium confidence

This page describes PagerDuty Workflow Automation, a product that automates manual business processes for development and IT operations by combining human-in-the-loop steps such as approvals and decisions with technical automation.

Developer ToolsEnterprise SoftwareSaaSChicago, US

Peter Barris(Director)Sean Chou(Executive Officer, Director)Ravi Singh(Executive Officer, Director)

Board seatPeter Barris· per SEC Form D · $5.6M raise · filed Jul 2018

Cleo Labscleolabs.coin 𝕏SEC filingmedium confidence

Cleo provides software for compliance teams that automates regulatory monitoring and analysis while keeping human judgment central to decision-making.

AI & Machine LearningEnterprise SoftwareLegalTechSan Francisco, US

Shannon Spanhake(Executive Officer, Director)Sarah Guo(Director)Vanessa Larco(Director)Former Chief Transformation Officer at Havas Group(Co-founder & CEO)AI Researcher(Co-founder & Chief Research Officer)Software engineer(CTO)

Board seatVanessa Larco· per SEC Form D · $32.4M raise · filed Dec 2020

ComplexaSEC filingmedium confidence

BiotechPittsburgh, US

Joshua M. Tarnoff(Executive Officer, Director)I. Wistar Morris(Director)H. Joseph Reiser(Director)Kenji Harada(Director)Miwa Toyoda(Director)Diane Jorkasky(Chief Medical Officer)

Board seatDavid Mott· per SEC Form D · $62.6M raise · filed Jul 2017

Coravincoravin.comSEC filingmedium confidence

Burlington, US

Jerome Chevalier(Director)Joshua Makower(Director)Frederic Levy(Executive Officer, Director)Greg Lambrecht(Executive Officer, Director)

Board seatJoshua Makower· per SEC Form D · $15M raise · filed Jun 2015

CRISPR Therapeutics AGSEC filingmedium confidence

BiotechBasel

Kurt von Emster(Director)Sven Ante Lundberg(Executive Officer)Thomas Woiwode(Director)Ali Behbahani(Director)Rodger Novak(Executive Officer, Director)Pablo Cagnoni(Director)

Board seatAli Behbahani· per SEC Form D · $1M raise · filed Apr 2020

Curisiumcurisium.comSEC filingmedium confidence

Manhattan Beach, US

Peter Kim(Executive Officer, Director, Promoter)Francis Lam(Executive Officer, Director, Promoter)Bill Geary(Director)Mohamad Makhzoumi(Director)

Board seatMohamad Makhzoumi· per SEC Form D · $1.2M raise · filed Jan 2018

Curzion Pharmaceuticals IncSEC filingmedium confidence

BiotechSan Diego, US

Kyle Rasbach(Director)Johan Kordel(Director)Mike Grey(Executive Officer, Director)Ed Mathers(Director)Susan Dube(Executive Officer)

BoardNiall O'Donnell(Director)

Board seatEd Mathers· per SEC Form D · $3.5M raise · filed Jul 2019

Data Robotdatarobot.cominSEC filingmedium confidence

DataRobot develops an AI and machine learning platform that automates model development and deployment for enterprises.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareBoston, US

Jeremy Achin(Executive Officer, Director, Promoter)Harry Weller(Director)Thomas de Godoy(Executive Officer, Director, Promoter)Christopher Lynch(Director)

Board seatTony FlorenceHilarie Koplow-McAdams· per SEC Form D · $320M raise · filed Dec 2020

Datafolddatafold.comin 𝕏SEC filingmedium confidence

Datafold builds AI-powered agents and tools that automate complex data engineering tasks including migrations, optimization, CI/CD, and data quality validation.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSNew York City, US

Gleb Mezhanskiy(Founder)inAlex Morozov(Founder)inAaron Jacobson(Director)Peter Sonsini(Director)

Board seatAaron Jacobson· per SEC Form D · $7M raise · filed May 2025

Docent HealthSEC filingmedium confidence

HealthtechCambridge, US

Trevor Price(Director)Mohamad Makhzoumi(Director)Ambar Bhattacharyya(Director)Steven Kraus(Director)Paul Roscoe(President, Treasurer, Secretary and Director of Issuer)

Board seatMohamad Makhzoumi· per SEC Form D · $17.1M raise · filed Jul 2016

EBH HoldingSEC filingmedium confidence

HealthtechLong Beach, US

Keith Arnold(Executive Officer)Richard Whitney(Director)DAVID KOSLOFF(Director)Rob Mahan(Executive Officer)Jim Adams(Executive Officer)Vera Appleyard(Executive Officer)

Board seatMohamad Makhzoumi· per SEC Form D · $14.4M raise · filed Nov 2015

Enigmaenigma.comin 𝕏SEC filingmedium confidence

Enigma aggregates and analyzes public and third-party data to provide intelligence on the identity and financial health of small and medium businesses in the United States.

Data & InfrastructureEnterprise SoftwareFintechNew York, US

Scott Sandell(Director)Hicham Oudghiri(Executive Officer, Director)Ben Narasin(Director)Andrew Cleland(Director)Marc DaCosta(Executive Officer, Director)

Board seatScott Sandell· per SEC Form D · $28.2M raise · filed Jul 2015

Envisia TherapeuticsSEC filingmedium confidence

BiotechMorrisville, US

Ed Mathers(Director)Adrienne Graves(Director)Stephen Bloch(Director)Ben Yerxa(Executive Officer)Gary Phillips(Director)Seth Rudnick(Director)

Board seatEd Mathers· per SEC Form D · $5.1M raise · filed Oct 2015

Evident IDSEC filingmedium confidence

Alpharetta, US

David Thomas(Executive Officer, Director)

Board seatVanessa Larco· per SEC Form D · $20.1M raise · filed May 2019

Fabric8Labsfabric8labs.cominSEC filingmedium confidence

Fabric8Labs develops Electrochemical Additive Manufacturing (ECAM), a metal 3D printing technology used to produce high-performance components at scale.

Advanced ManufacturingHardwareSemiconductorsSan Diego, US

Jeffrey Herman(Executive Officer, Director)David Pain(Director)

BoardCyril Vancura(Director)Jennifer Ard(Director)

Board seatGreg Papadopoulos· per SEC Form D · $56.5M raise · filed Jan 2026

Firestorm LabsSEC filingmedium confidence

Defense ecosystem company with special operations connections

San Diego, US

Daniel Magy(Executive Officer, Director, Promoter)Ian Muceus(Executive Officer, Director, Promoter)

BoardTommy Hendrix(Director)

Board seatAaron Jacobson· per SEC Form D · $75M raise · filed Mar 2026

FirstLight Bio, Inc.SEC filingmedium confidence

BiotechNew York, US

Hunter Fraser(Director)Ali Behbahani(Director)Carlo Rizzuto, Ph.D.(Executive Officer, Director)Busser Busser, Ph.D.(Executive Officer)

Board seatAli Behbahani· per SEC Form D · $25.4M raise · filed Apr 2022

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Fund performance · per public LP disclosures · 19

as of Sep 2025

Fund	Vintage	Committed	Net IRR	TVPI	DPI
NEA SH 2025 SPVLPs: Orange County Employees Retirement System	2025	—	—	1.00x	—
NEA 18 VentureLPs: Los Angeles City Employees' Retirement System	2022	—	1.8%	1.03x	0.00x
NEA 18 Venture Growth EquityLPs: California State Teachers' Retirement System, Los Angeles City Employees' Retirement System, Orange County Employees Retirement System	2022	—	11.6%	1.20x	—
New Enterprise Associates 18LPs: Nebraska Investment Council, Los Angeles City Employees' Retirement System, California State Teachers' Retirement System +2 more	2022	—	40.5%	1.86x	0.11x
New Enterprise Associates 18rLPs: Orange County Employees Retirement System	2022	—	41.0%	2.00x	0.11x
New Enterprise Associates 17LPs: California State Teachers' Retirement System, Nebraska Investment Council, Los Angeles City Employees' Retirement System +2 more	2019	—	4.5%	1.17x	0.16x
New Enterprise Associates 16LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +1 more	2017	—	8.2%	1.52x	0.42x
NEA 15 Opportunity Fund, L.P.LPs: North Carolina Retirement Systems, California State Teachers' Retirement System	2015	—	25.2%	3.68x	1.44x
NEA 15, L.P.LPs: North Carolina Retirement Systems	2015	—	11.3%	1.83x	1.03x
New Enterprise Associates 15LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +2 more	2015	—	10.0%	1.75x	1.05x
NEA 14, L.P.LPs: North Carolina Retirement Systems	2012	—	14.9%	2.71x	1.14x
New Enterprise Associates 13LPs: California State Teachers' Retirement System, Nebraska Investment Council, New Mexico Public Employees Retirement Association +3 more	2008	—	—	2.76x	2.57x
New Enterprise Associates 12, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +3 more	2006	—	6.4%	1.40x	1.39x
New Enterprise Associates 11LPs: California State Teachers' Retirement System, Pennsylvania Public School Employees' Retirement System, Hawaii Employees' Retirement System	2004	—	15.3%	2.65x	2.57x
New Enterprises Associates VIII A, L.P.LPs: California State Teachers' Retirement System	2001	—	-2.4%	0.79x	0.79x
New Enterprise Associates 10, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +2 more	2000	—	2.3%	1.20x	1.13x
New Enterprise Associates 9, L.P.LPs: California State Teachers' Retirement System, Hawaii Employees' Retirement System, John S. and James L. Knight Foundation	1999	—	-6.1%	0.46x	0.46x
New Enterprises Associates VIII, L.P.LPs: California State Teachers' Retirement System	1998	—	30.6%	1.66x	1.64x
NEW ENTERPRISE ASSOCIATES 14, L.P.LPs: California State Teachers' Retirement System, New Mexico Public Employees Retirement Association, Hawaii Employees' Retirement System +3 more	—	—	—	3.31x	1.50x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

What stage does New Enterprise Associates (NEA) invest at?: New Enterprise Associates (NEA) invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is New Enterprise Associates (NEA)'s typical check size?: New Enterprise Associates (NEA) typically writes checks of $200K – $40M.
What sectors does New Enterprise Associates (NEA) focus on?: New Enterprise Associates (NEA) focuses on AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Sector Agnostic.
Where is New Enterprise Associates (NEA) located?: New Enterprise Associates (NEA) is headquartered in Menlo Park, US.
Does New Enterprise Associates (NEA) lead rounds?: Yes, New Enterprise Associates (NEA) leads investment rounds.

Media · Podcasts & interviews

featuring the team

NEA's Scott Sandell May Have The Most IPOs Of All Time. Here's How He Did It | Ep. 10 I/O Podcast

IO Podcast · Scott Sandell

Keynote Fireside Chat with Scott Sandell - Chairman, CEO & Chief Investment Officer, NEA

MIT Initiative on the Digital Economy · Scott Sandell

Scott Sandell | How to last for 100 years in venture capital

Slush · Scott Sandell

AI for Science : Algorithms to Atoms

NEA VC

Building a Better Future – NEA Companies on a Mission

NEA VC

Optimatik & Forethought:Building Generative AI Companies In a Rapidly Evolving Market

NEA VC

Images

Co-investors · 396

Andreessen Horowitz

Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.

Both backed · 10

BuzzFeed CCP Games Cowboy Space Corporation Databricks Kindred Plaid Robinhood Smartcar Swiftype Waymark

$500K – $50M

Intel Capital

Intel Capital is the corporate venture capital arm associated with Intel, investing in and supporting technology companies as they scale.

Both backed · 7

Catalytic Cohere Technologies Data Robot Fabric8Labs Metalenz Science Logic Twelve Labs

$1M – $20M

Techstars

Techstars is a startup accelerator and early-stage investor that funds ambitious founders and provides capital, mentorship, and access to a global network of investors, operators, and corporate partners.

Both backed · 6

Twilio AppSheet Data Robot Narmi Placester Twelve Labs

$220K

Index Ventures

Index Ventures is a venture capital firm that backs founders across the globe, investing in the people behind ideas from early through later stages.

Both backed · 6

Cowboy Space Corporation Kindred Patreon Plaid Robinhood Twelve Labs

$540K – $10.8M

Norwest Venture Partners

Norwest is a venture and growth equity investment firm that has backed over 700 companies across sectors including AI, retail, and healthcare, working alongside entrepreneurs from early to late-stage growth.

Both backed · 6

Mirum PharmaceuticalsNkarta, Inc.Arcellx Data Robot StarcityAsk Perplexity

$10M – $30M

Bessemer Venture Partners

Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.

Both backed · 5

Twilio Docent Kindred VirtruAsk Perplexity

$5M – $100M

Tiger Global Management

Tiger Global is a research-driven investment firm that partners with innovative, high-quality companies over the long term across various stages of their lifecycle.

Both backed · 5

Built Robotics Cohere Technologies Databricks Patreon Timescale

$1M – $100M

NewView Capital

NewView Capital is a venture capital firm that provides flexible capital to growth-stage companies, investing on a primary, secondary, or hybrid basis and offering operational guidance on scale-up decisions.

Both backed · 5

Acquia Databricks Horizon3 Ai Plaid Science Logic

GV (Google Ventures)

GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.

Both backed · 4

Monte Rosa Therapeutics Affinia Therapeutics Plaid Wonder Group

$250K – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.

Both backed · 4

Twilio Cloudflare TurnstileAsk PerplexityBright Health

$5K – $50M

Redpoint Ventures

Redpoint Ventures is a venture capital firm established in 1999 by former partners from leading venture firms, focusing on early-stage technology companies across multiple sectors. The firm leverages its partners' technology investment experience and an extensive network of entrepreneurs and industry contacts to support portfolio company growth.

Both backed · 4

Twilio Strive Health TimescaleBright Health

$100K – $10M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.

Both backed · 4

Coursera (Exit)Mashgin Robinhood Tesaro

$500K – $15M

▶384 more co-investors

Lux Capital Lightspeed Venture Partners SV Angel Menlo Ventures IVP (Institutional Venture Partners)Union Square Ventures (USV)SignalFire PICUS CAPITAL Comcast Ventures OrbiMed Flare Capital Partners Versant Ventures SR One Capital Management Sanofi Ventures Ascension Ventures Aisling Capital Evolution VC Partners Sequoia Capital Founders Fund Accel Notable Capital Benchmark Felicis Ventures Bain Capital Ventures B Capital Group Sapphire Ventures Battery Ventures Susa Ventures ACME Capital RRE Ventures Greycroft Acrew Capital Lerer Hippeau Atlas Venture Winklevoss Capital CapitalG AlleyCorp 9Yards Capital RA Capital 137 Ventures Construct Capital Artis Ventures Runa Capital The Column Group Abingworth Sofinnova Ventures CVS Health Ventures Red & Blue Ventures General Catalyst Craft Ventures Insight Partners BoxGroup Coatue Management Spark Capital CRV (Charles River Ventures)DST Global Great Oaks Venture Capital Canaan Partners Streamlined Ventures Slow Ventures Oak HC/FT Madrona Venture Group Canvas Ventures Flybridge Capital Partners Cota Capital F-Prime Capital Partners Soma Capital 8VC Maveron Venrock Ridge Ventures Thrive Capital Social Leverage Kortschak Investments L.P.Accomplice Matrix Shasta Ventures Chemistry Eclipse Ventures Standard Capital Next Play Ventures AIX Ventures Tenaya Capital Ballistic Ventures MaC Venture Capital August Capital ICONIQ Capital Viola Ventures Qualcomm Ventures Javelin Venture Partners Third Point Ventures Breakthrough Energy Ventures Storm Ventures Crosscut Ventures HOF Capital Owl Ventures Helium-3 Ventures Multicoin Capital Basis Set Ventures Greenoaks Radical Ventures Amplo Ventures Pitango Race Capital Amity Ventures Alpaca VC EQT Life Sciences Neotribe Ventures OUP (Osage University Partners)Dimension Capital Illuminate Ventures 5AM Ventures Cerity Partners Ventures Tola Capital Cervin Pfizer Venture Investments 7wire Ventures Foresite Capital GSV Ventures Green Bay Ventures Ysios Capital Lightstone Ventures Tensility Venture Partners Energize Ventures Harpoon Ventures Vensana Capital RiverVest Venture Lam Capital HBM Partners Velvet Sea Ventures Greylock Partners Alumni Ventures Long Journey Ventures Founder Collective Uncork Capital Unknown Ventures First Round Capital Uber Foundation Capital Everywhere Ventures Kraken True Ventures Balderton Capital Eniac Ventures Quiet Capital SOSV Goat Capital FirstMark Offline Ventures Liquid Ventures NextView Ventures Bling Capital Hardware Club AME Cloud Ventures SciFi VC Freestyle Capital Innovation Endeavors Forerunner Ventures Accel-KKR Emergence Capital Partners Kapor Capital Obvious Ventures Stellar Capital Afore Capital Addition SoftBank Vision Fund Meritech Capital Partners Bond Capital Management Stride VC Bowery Capital Bonfire Ventures IA Ventures Sierra Ventures Trinity Ventures Trajectory Ventures Ribbit Capital Hack VC Not Boring Capital 01 Advisors Paradigm DCM Ventures Goodwater Capital Harrison Metal Pear VC Hanabi Capital QueensBridge Venture Partners Tq Ventures Llc EQT Ventures Wing Global Founders Capital Gaingels Salesforce Japan Co.,Ltd.WGI Group Northzone Costanoa Ventures The Chernin Group (TCG Crypto)Speedinvest MS&AD Ventures Betaworks Ventures Management, Llc Cowboy Ventures General Atlantic HV Capital 23andMe Draper Fisher Jurvetson (DFJ)Pelion Venture Partners Dreamers VC Left Lane Capital Digital Currency Group Webb Investment Network Energy Impact Partners Lakestar ARCH Venture Partners Transmedia Capital Hyde Park Venture Partners Company Capital Decibel Partners OMERS Ventures Spider Capital 2xN Polychain Capital Valar Ventures American Express Ventures (Amex)Cisco Investments FELIX CAPITAL Coelius Capital The Finger Group Ff Venture Capital Kohlberg Kravis Roberts Allison Pickens Ventures Unpopular Ventures Giant Ventures Global Llp Mosaic Ventures xfactor ventures Prefix Capital Preston-Werner Ventures Formation Group La Famiglia Team8 Walden International K2 Global MMC Ventures White Star Capital Collaborative Fund (Collab Fund)Future Perfect Ventures Scrum Ventures Alven StageOne Ventures UP Partners BlueRun Ventures Jetstream Silverton Partners Amasia Endeavor Catalyst Fusion Voyager Capital Highbury Holdings Presight Capital Signia Venture Partners Active Capital Ensemble VC Think+ Ventures Management, Llc Next Coast Ventures Root Ventures Manager, Llc Euclid Venture Partners WestWave Capital Sutter Hill Ventures AI Fund GE Ventures Primitive Ventures H.I.G. Growth Partners JAZZ Venture Partners Paladin Capital Group TMV Logistics Prelude Ventures BINARY CAPITAL Miramar Venture Partners Northpond Ventures FYRFLY Venture Partners Jump Capital Moonfire Ventures Gutbrain Ventures BootstrapLabs S Capital WestCap Learn Capital Moderne Ventures Walden Catalyst Ventures Cultivation Capital Arrive AV8 Ventures MVP Ventures Forbion Atlantic Bridge Ventures f7 Ventures Builders VC Deerfield Management Company Ligature VC Mysten Labs redalpine Redpoint eventures Xplorer Capital Elaia Metamorphic Ventures Slack Fund venBio Partners Domain Associates Tuesday Capital SparkLabs Global Ventures LiveOak Venture Partners Prime Movers Lab Bain Capital Venture Patron Granite Asia Marathon Venture Capital Stanford University Cavalry Ventures Firefly Health MizMaa Ventures Listen Ventures Zintinus Arboretum Ventures Morgenthaler Novartis Venture Fund OCA Ventures Roosh Ventures Big Idea Ventures Imaginary Venture Capital Arthur Ventures Frazier Healthcare Partners Max Ventures Rethink Capital Partners Amara VC Core Innovation Capital Energy Capital Ventures Arbor Ventures Nextech Invest Optum Ventures Celonis Morpheus Ventures Omega Funds Roche Venture Fund Ansa Capital Makers Camp Elephant Partners Vida Ventures NTT Venture Capital Core Venture Capital Maverick Capital Leadout Capital Matter Venture Partners StarVest Partners Mercury Fund 17Sigma humbition Agent Capital BCF Ventures Chainforest 4BIO Capital America's Frontier Fund Geekdom Collide Capital Okapi Venture Capital OpenCapital.vc TriplePoint Capital Upheaval Investments Wealthing VC Club JDRF T1D Fund Planeteer Capital Sante Ventures Turing Capital Voyager Partners Florida Funders Samsung Ventures Mohr Davidow Ventures Outliers VC Pappas Capital Clarus Ventures Cosmic Venture Partners Quadrille Capital Sancus Ventures Able Partners 82VS Nest.Bio Ventures Single Fin Ventures

Firms observed investing alongside New Enterprise Associates (NEA), from public investor directories. Shared companies are the overlap with New Enterprise Associates (NEA)'s recorded portfolio.

Similar investors

Bessemer Venture Partners

$5M – $100M

General Catalyst

General Catalyst is a venture capital and investment firm that backs founders across industries, with a strong focus on AI-driven transformation, fintech, healthcare, and other sectors.

$30M

Khosla Ventures

Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.

$5K – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.

$500K – $15M

Sequoia Capital

Sequoia Capital is a venture capital firm that partners with founders to build technology companies, with a strong current focus on artificial intelligence.

$4.4M – $214M